Table 1.
Baseline characteristics of the patient cohort
| Variables | |
|---|---|
| No. of patients | 59 |
| Age (years) | 63 ± 9 |
| Male gender | 41 (70%) |
| Body mass index (kg/m2) | 27 ± 4 |
| Risk factors | |
| Family history of CAD | 31 (53%) |
| Hypertension | 40 (68%) |
| Dyslipidemia | 41 (70%) |
| Diabetes mellitus | 5 (9%) |
| Smoking | 28 (48%) |
| Medication | |
| ACE inhibitor or ATII antagonist | 23 (39%) |
| Aspirin | 58 (98%) |
| Beta-blocker | 33 (56%) |
| Calcium channel blockers | 18 (30%) |
| Long-acting nitrates | 18 (30%) |
| Statin | 50 (85%) |
| Symptoms | |
| Asymptomatic | 3 (5%) |
| Dyspnea | 14 (24%) |
| Non-anginal chest pain | 5 (9%) |
| Atypical angina | 17 (29%) |
| Typical angina | 20 (34%) |
Data are mean ± standard deviation or absolute number (%). ACE , angiotensin-converting-enzyme; ATII ,angiotensin II receptor; CAD ,coronary artery disease